Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

miR-218 Suppresses Nasopharyngeal Cancer Progression through Downregulation of Survivin and the SLIT2-ROBO1 Pathway

(2011) N. M. Alajez et al.   CANCER RESEARCH

The Tumor Suppressive MicroRNA miR-218 Targets the mTOR Component Rictor and Inhibits AKT Phosphorylation in Oral Cancer

(2011) A. Uesugi et al.   CANCER RESEARCH

miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β

(2010) Libing Song et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Paxillin Predicts Survival and Relapse in Non-Small Cell Lung Cancer by MicroRNA-218 Targeting

(2010) D.-W. Wu et al.   CANCER RESEARCH

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis

(2010) Nobuyoshi Kosaka et al.   CANCER SCIENCE

MicroRNA-218 Regulates Vascular Patterning by Modulation of Slit-Robo Signaling

(2010) Eric M. Small et al.   CIRCULATION RESEARCH

Serum microRNAs as non-invasive biomarkers for cancer

(2010) Jan C Brase et al.   Molecular Cancer

MiR-218 Inhibits Invasion and Metastasis of Gastric Cancer by Targeting the Robo1 Receptor

(2010) Jun Tie et al.   PLoS Genetics

Adenocarcinoma: A unique cervical cancer

(2009) Lilian T. Gien et al.   GYNECOLOGIC ONCOLOGY

Altered MicroRNA Expression in Cervical Carcinomas

(2008) J.-W. Lee et al.   CLINICAL CANCER RESEARCH

miR-21 plays a pivotal role in gastric cancer pathogenesis and progression

(2008) Zhiyu Zhang et al.   LABORATORY INVESTIGATION